ANIP
Price
$70.19
Change
-$1.27 (-1.78%)
Updated
Sep 11 closing price
Capitalization
1.61B
60 days until earnings call
Intraday BUY SELL Signals
PBH
Price
$46.95
Change
-$0.39 (-0.82%)
Updated
Sep 11 closing price
Capitalization
2.22B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANIP vs PBH

ANIP vs PBH Comparison Chart in %
View a ticker or compare two or three
VS
ANIP vs. PBH commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a StrongBuy and PBH is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($2.22B) has a higher market cap than ANIP($1.62B). ANIP has higher P/E ratio than PBH: ANIP (15.32) vs PBH (13.15). ANIP YTD gains are higher at: -11.084 vs. PBH (-23.894). PBH has higher annual earnings (EBITDA): 313M vs. ANIP (245M). ANIP has more cash in the bank: 376M vs. PBH (89.1M). ANIP has less debt than PBH: ANIP (610M) vs PBH (2.07B). PBH has higher revenues than ANIP: PBH (1.11B) vs ANIP (978M).
ANIPPBHANIP / PBH
Capitalization1.62B2.22B73%
EBITDA245M313M78%
Gain YTD-11.084-23.89446%
P/E Ratio15.3213.15116%
Revenue978M1.11B89%
Total Cash376M89.1M422%
Total Debt610M2.07B30%
FUNDAMENTALS RATINGS
ANIP vs PBH: Fundamental Ratings
ANIP
PBH
OUTLOOK RATING
1..100
6374
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
41100
SMR RATING
1..100
4874
PRICE GROWTH RATING
1..100
6174
P/E GROWTH RATING
1..100
9858
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBH's Valuation (68) in the Pharmaceuticals Other industry is in the same range as ANIP (89). This means that PBH’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's Profit vs Risk Rating (41) in the Pharmaceuticals Other industry is somewhat better than the same rating for PBH (100). This means that ANIP’s stock grew somewhat faster than PBH’s over the last 12 months.

ANIP's SMR Rating (48) in the Pharmaceuticals Other industry is in the same range as PBH (74). This means that ANIP’s stock grew similarly to PBH’s over the last 12 months.

ANIP's Price Growth Rating (61) in the Pharmaceuticals Other industry is in the same range as PBH (74). This means that ANIP’s stock grew similarly to PBH’s over the last 12 months.

PBH's P/E Growth Rating (58) in the Pharmaceuticals Other industry is somewhat better than the same rating for ANIP (98). This means that PBH’s stock grew somewhat faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPPBH
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
55%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 11 days ago
54%
Declines
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 2 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
50%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ANIP: $70.19 vs. PBH: $46.95)
Brand notoriety: ANIP and PBH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ANIP: 90% vs. PBH: 99%
Market capitalization -- ANIP: $1.61B vs. PBH: $2.22B
ANIP [@Pharmaceuticals: Generic] is valued at $1.61B. PBH’s [@Pharmaceuticals: Generic] market capitalization is $2.22B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green while PBH’s FA Score has 0 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • PBH’s FA Score: 0 green, 5 red.
According to our system of comparison, ANIP is a better buy in the long-term than PBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 3 TA indicator(s) are bullish while PBH’s TA Score has 4 bullish TA indicator(s).

  • ANIP’s TA Score: 3 bullish, 6 bearish.
  • PBH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PBH is a better buy in the short-term than ANIP.

Price Growth

ANIP (@Pharmaceuticals: Generic) experienced а -1.46% price change this week, while PBH (@Pharmaceuticals: Generic) price change was -10.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

Reported Earning Dates

ANIP is expected to report earnings on Nov 11, 2026.

PBH is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
ANIP
Daily Signal:
Gain/Loss:
PBH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XHB98.461.55
+1.60%
State Street® SPDR® S&P® Hmebldr ETF
HEQT34.330.24
+0.72%
Simplify Hedged Equity ETF
PBL33.520.17
+0.50%
PGIM Portfolio Ballast ETF
BNDS50.010.07
+0.14%
Infrastructure Capital Bond Income ETF
MEXX27.590.01
+0.02%
Direxion Dly MSCI Mexico Bull 3X ShsETF

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with HLN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
-0.82%
HLN - PBH
34%
Loosely correlated
-0.33%
PRGO - PBH
33%
Poorly correlated
+0.52%
ELAN - PBH
29%
Poorly correlated
+1.36%
TAK - PBH
27%
Poorly correlated
+0.83%
HCM - PBH
26%
Poorly correlated
-2.29%
More